# Treatment of Thromboangiitis Obliterans (Buerguer's Disease) With Bosentan

> **NCT01447550** · — · COMPLETED · sponsor: **Hospital Universitario Getafe** · enrollment: 12 (actual)

## Conditions studied

- Thromboangiitis Obliterans

## Interventions

- **DRUG:** Bosentan

## Key facts

- **NCT ID:** NCT01447550
- **Lead sponsor:** Hospital Universitario Getafe
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2016-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01447550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01447550, "Treatment of Thromboangiitis Obliterans (Buerguer's Disease) With Bosentan". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01447550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*